Behind the Insights: Ep 05 Rheumatoid Arthritis Remission with Chandra Gopalakrishnan, MD, MPH
Impossibile aggiungere al carrello
Rimozione dalla Lista desideri non riuscita.
Non è stato possibile aggiungere il titolo alla Libreria
Non è stato possibile seguire il Podcast
Esecuzione del comando Non seguire più non riuscita
Behind the Insights: Ep 05 Rheumatoid Arthritis Remission with Chandra Gopalakrishnan, MD, MPH
-
Letto da:
-
Di:
A proposito di questo titolo
In this episode of Behind the Insights, Chandra Gopalakrishnan, MD, MPH, Principal Epidemiologist at OM1, discusses an award winning ISPOR poster that investigates predictors of low disease activity or remission in rheumatoid arthritis (RA). Despite the vast availability of therapies, many rheumatoid arthritis patients still fail to achieve remission, highlighting the need for more effective treatment strategies.
0:00 Intro
0:42 RA patients with prior inadequate response to biologic DMARDS
1:37 Uncovering predictive trends with OM1's PremiOM RA dataset
2:27 Comorbid insights, decision-making, and personalized treatment
3:27 Capturing estimated Clinical Disease Activity Index (CDAI) for better capture disease control
4:24 Effect on the treatment landscape and innovations
📩 Stay updated on future episodes: https://go.om1.com/l/1071043/2025-02-10/bk8151
🎯 Follow us! LinkedIn: https://www.linkedin.com/company/om1-inc./
Facebook: https://www.facebook.com/profile.php?id=61573205886660
X: https://x.com/Om1Inc
🌐 Visit our website: https://www.om1.com/
#rheumatology #rheum #rheumatoidarthritis #cdai #realworlddata #rwd #realworldevidence #rwe #clinicalresearch #pharma